{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:49:24Z","timestamp":1781711364965,"version":"3.54.5"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institutes of Health's National Center for Advancing Translational Sciences","award":["KL2TR001424"],"award-info":[{"award-number":["KL2TR001424"]}]},{"name":"National Institutes of Health's National Center for Advancing Translational Sciences","award":["UL1TR001422"],"award-info":[{"award-number":["UL1TR001422"]}]},{"name":"National Institutes of Health's National Institute of Neurological Disease and Stroke","award":["K08NS097264"],"award-info":[{"award-number":["K08NS097264"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40478-019-0727-1","type":"journal-article","created":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T10:04:06Z","timestamp":1557914646000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Tenascin-C expression contributes to pediatric brainstem glioma tumor phenotype and represents a novel biomarker of disease"],"prefix":"10.1186","volume":"7","author":[{"given":"J.","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. R.","family":"Esfahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ozark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bartom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hashizume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. R.","family":"Bonner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. M.","family":"Horbinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. D.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Saratsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,15]]},"reference":[{"key":"727_CR1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders S, Pyl PT, Huber W (2015) HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics 31:166\u2013169. https:\/\/doi.org\/10.1093\/bioinformatics\/btu638","journal-title":"Bioinformatics"},{"key":"727_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s40478-016-0349-9","volume":"4","author":"A Araki","year":"2016","unstructured":"Araki A, Chocholous M, Gojo J, Dorfer C, Czech T, Heinzl H, Dieckmann K, Ambros IM, Ambros PF, Slavc I et al (2016) Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma. Acta Neuropathol Commun 4:88. https:\/\/doi.org\/10.1186\/s40478-016-0349-9","journal-title":"Acta Neuropathol Commun"},{"key":"727_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/BF02893856","volume":"11","author":"S Behrem","year":"2005","unstructured":"Behrem S, Zarkovic K, Eskinja N, Jonjic N (2005) Distribution pattern of tenascin-C in glioblastoma: correlation with angiogenesis and tumor cell proliferation. Pathol Oncol Res 11:229\u2013235 Doi Paor.2005.11.4.0229","journal-title":"Pathol Oncol Res"},{"key":"727_CR4","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1002\/cncr.21534","volume":"104","author":"V Bernier-Chastagner","year":"2005","unstructured":"Bernier-Chastagner V, Grill J, Doz F, Bracard S, Gentet JC, Marie-Cardine A, Luporsi E, Margueritte G, Lejars O, Laithier V et al (2005) Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II study. Cancer 104:2792\u20132797. https:\/\/doi.org\/10.1002\/cncr.21534","journal-title":"Cancer"},{"key":"727_CR5","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114\u20132120. https:\/\/doi.org\/10.1093\/bioinformatics\/btu170","journal-title":"Bioinformatics"},{"issue":"2","key":"727_CR6","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","volume":"155","author":"Cameron\u00a0W. Brennan","year":"2013","unstructured":"Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH et al (2013) The somatic genomic landscape of glioblastoma. Cell 155:462\u2013477. https:\/\/doi.org\/10.1016\/j.cell.2013.09.034","journal-title":"Cell"},{"issue":"1-2","key":"727_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/19336918.2014.1000071","volume":"9","author":"Nicole Br\u00f6sicke","year":"2015","unstructured":"Brosicke N, Faissner A (2015) Role of tenascins in the ECM of gliomas. Cell Adhes Migr 9:131\u2013140. https:\/\/doi.org\/10.1080\/19336918.2014.1000071","journal-title":"Cell Adhesion & Migration"},{"key":"727_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00441-013-1704-9","volume":"354","author":"N Brosicke","year":"2013","unstructured":"Brosicke N, van Landeghem FK, Scheffler B, Faissner A (2013) Tenascin-C is expressed by human glioma in vivo and shows a strong association with tumor blood vessels. Cell Tissue Res 354:409\u2013430. https:\/\/doi.org\/10.1007\/s00441-013-1704-9","journal-title":"Cell Tissue Res"},{"key":"727_CR9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/ng.2936","volume":"46","author":"P Buczkowicz","year":"2014","unstructured":"Buczkowicz P, Hoeman C, Rakopoulos P, Pajovic S, Letourneau L, Dzamba M, Morrison A, Lewis P, Bouffet E, Bartels U et al (2014) Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat Genet 46:451\u2013456. https:\/\/doi.org\/10.1038\/ng.2936","journal-title":"Nat Genet"},{"key":"727_CR10","doi-asserted-by":"publisher","unstructured":"Cai J, Du S, Wang H, Xin B, Wang J, Shen W, Wei W, Guo Z, Shen X (2017) Tenascin-C induces migration and invasion through JNK\/c-Jun signalling in pancreatic cancer. Oncotarget 8:74406\u201374422. https:\/\/doi.org\/10.18632\/oncotarget.20160","DOI":"10.18632\/oncotarget.20160"},{"issue":"40","key":"727_CR11","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.1038\/onc.2008.155","volume":"27","author":"A Calvo","year":"2008","unstructured":"Calvo A, Catena R, Noble MS, Carbott D, Gil-Bazo I, Gonzalez-Moreno O, Huh JI, Sharp R, Qiu TH, Anver MR et al (2008) Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis. Oncogene 27:5373","journal-title":"Oncogene"},{"key":"727_CR12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrg2540","volume":"10","author":"H Cedar","year":"2009","unstructured":"Cedar H, Bergman Y (2009) Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 10:295\u2013304. https:\/\/doi.org\/10.1038\/nrg2540","journal-title":"Nat Rev Genet"},{"issue":"9","key":"727_CR13","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1101\/gad.217778.113","volume":"27","author":"K.-M. Chan","year":"2013","unstructured":"Chan KM, Fang D, Gan H, Hashizume R, Yu C, Schroeder M, Gupta N, Mueller S, James CD, Jenkins R et al (2013) The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression. Genes Dev 27:985\u2013990. https:\/\/doi.org\/10.1101\/gad.217778.113","journal-title":"Genes & Development"},{"issue":"2","key":"727_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s11060-011-0681-7","volume":"106","author":"Andrea Chassot","year":"2011","unstructured":"Chassot A, Canale S, Varlet P, Puget S, Roujeau T, Negretti L, Dhermain F, Rialland X, Raquin MA, Grill J et al (2012) Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. J Neuro-Oncol 106:399\u2013407. https:\/\/doi.org\/10.1007\/s11060-011-0681-7","journal-title":"Journal of Neuro-Oncology"},{"key":"727_CR15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1530\/rep-07-0289","volume":"134","author":"G Chevillard","year":"2007","unstructured":"Chevillard G, Derjuga A, Devost D, Zingg HH, Blank V (2007) Identification of interleukin-1beta regulated genes in uterine smooth muscle cells. Reproduction 134:811\u2013822. https:\/\/doi.org\/10.1530\/rep-07-0289","journal-title":"Reproduction"},{"key":"727_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/19336918.2015.1008333","volume":"9","author":"F Chiovaro","year":"2015","unstructured":"Chiovaro F, Chiquet-Ehrismann R, Chiquet M (2015) Transcriptional regulation of tenascin genes. Cell Adhes Migr 9:34\u201347. https:\/\/doi.org\/10.1080\/19336918.2015.1008333","journal-title":"Cell Adhes Migr"},{"key":"727_CR17","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/neuonc\/noq205","volume":"13","author":"KJ Cohen","year":"2011","unstructured":"Cohen KJ, Heideman RL, Zhou T, Holmes EJ, Lavey RS, Bouffet E, Pollack IF (2011) Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's oncology group. Neuro-Oncology 13:410\u2013416. https:\/\/doi.org\/10.1093\/neuonc\/noq205","journal-title":"Neuro-Oncology"},{"key":"727_CR18","doi-asserted-by":"publisher","first-page":"12310","DOI":"10.1523\/JNEUROSCI.4957-09.2010","volume":"30","author":"T Czopka","year":"2010","unstructured":"Czopka T, von Holst A, Ffrench-Constant C, Faissner A (2010) Regulatory mechanisms that mediate tenascin C-dependent inhibition of oligodendrocyte precursor differentiation. J Neurosci 30:12310\u201312322. https:\/\/doi.org\/10.1523\/JNEUROSCI.4957-09.2010","journal-title":"J Neurosci"},{"key":"727_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH752>3.0.CO;2-V","volume":"193","author":"N Dandachi","year":"2001","unstructured":"Dandachi N, Hauser-Kronberger C, Mor\u00e9 E, Wiesener B, Hacker GW, Dietze O, Wirl G (2001) Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins. J Pathol 193:181\u2013189. https:\/\/doi.org\/10.1002\/1096-9896(2000)9999:9999<::AID-PATH752>3.0.CO;2-V","journal-title":"J Pathol"},{"key":"727_CR20","doi-asserted-by":"publisher","first-page":"5260","DOI":"10.1073\/pnas.1308663111","volume":"111","author":"RL Daugherty","year":"2014","unstructured":"Daugherty RL, Serebryannyy L, Yemelyanov A, Flozak AS, Yu HJ, Kosak ST, deLanerolle P, Gottardi CJ (2014) \u03b1-Catenin is an inhibitor of transcription. Proc Natl Acad Sci U S A 111:5260\u20135265. https:\/\/doi.org\/10.1073\/pnas.1308663111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"727_CR21","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1096\/fj.03-1110fje","volume":"18","author":"O De Wever","year":"2004","unstructured":"De Wever O, Nguyen Q-D, Van Hoorde L, Bracke M, Bruyneel E, Gespach C, Mareel M (2004) Tenascin-C and SF\/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEB J 18:1016\u20131018. https:\/\/doi.org\/10.1096\/fj.03-1110fje","journal-title":"FASEB J"},{"key":"727_CR22","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2017.1391972","volume":"7","author":"V Dutoit","year":"2018","unstructured":"Dutoit V, Migliorini D, Ranzanici G, Marinari E, Widmer V, Lobrinus JA, Momjian S, Costello J, Walker PR, Okada H et al (2018) Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma. Oncoimmunology 7:e1391972. https:\/\/doi.org\/10.1080\/2162402x.2017.1391972","journal-title":"Oncoimmunology"},{"key":"727_CR23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1126\/science.aao4750","volume":"360","author":"MG Filbin","year":"2018","unstructured":"Filbin MG, Tirosh I, Hovestadt V, Shaw ML, Escalante LE, Mathewson ND, Neftel C, Frank N, Pelton K, Hebert CM et al (2018) Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq. Science 360:331\u2013335. https:\/\/doi.org\/10.1126\/science.aao4750","journal-title":"Science"},{"key":"727_CR24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3171\/2008.11.peds08281","volume":"3","author":"JL Frazier","year":"2009","unstructured":"Frazier JL, Lee J, Thomale UW, Noggle JC, Cohen KJ, Jallo GI (2009) Treatment of diffuse intrinsic brainstem gliomas: failed approaches and future strategies. J Neurosurg Pediatr 3:259\u2013269. https:\/\/doi.org\/10.3171\/2008.11.peds08281","journal-title":"J Neurosurg Pediatr"},{"key":"727_CR25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0360-3016(93)90228-N","volume":"27","author":"CR Freeman","year":"1993","unstructured":"Freeman CR, Krischer JP, Sanford RA, Cohen ME, Burger PC, del Carpio R, Halperin EC, Munoz L, Friedman HS, Kun LE (1993) Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a pediatric oncology group study. Int J Radiat Oncol Biol Phys 27:197\u2013206","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"727_CR26","doi-asserted-by":"crossref","unstructured":"Garcion E, Faissner A, Ffrench-Constant C (2001) Knockout mice reveal a contribution of the extracellular matrix molecule tenascin-C to neural precursor proliferation and migration. Development 128:2485\u20132496","DOI":"10.1242\/dev.128.13.2485"},{"issue":"10","key":"727_CR27","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1111\/j.1460-9568.2004.03727.x","volume":"20","author":"Jeremy Garwood","year":"2004","unstructured":"Garwood J, Garcion E, Dobbertin A, Heck N, Calco V, Ffrench-Constant C, Faissner A (2004) The extracellular matrix glycoprotein tenascin-C is expressed by oligodendrocyte precursor cells and required for the regulation of maturation rate, survival and responsiveness to platelet-derived growth factor. Eur J Neurosci 20:2524\u20132540. https:\/\/doi.org\/10.1111\/j.1460-9568.2004.03727.x","journal-title":"European Journal of Neuroscience"},{"key":"727_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4161\/19336918.2014.987587","volume":"9","author":"SP Giblin","year":"2015","unstructured":"Giblin SP, Midwood KS (2015) Tenascin-C: form versus function. Cell Adhes Migr 9:48\u201382. https:\/\/doi.org\/10.4161\/19336918.2014.987587","journal-title":"Cell Adhes Migr"},{"issue":"6","key":"727_CR29","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nm.3855","volume":"21","author":"Catherine S Grasso","year":"2015","unstructured":"Grasso CS, Tang Y, Truffaux N, Berlow NE, Liu L, Debily MA, Quist MJ, Davis LE, Huang EC, Woo PJ et al (2015) Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat Med 21:555\u2013559. https:\/\/doi.org\/10.1038\/nm.3855","journal-title":"Nature Medicine"},{"issue":"1","key":"727_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.0300-9475.2005.01524.x","volume":"61","author":"A. Gratchev","year":"2005","unstructured":"Gratchev A, Kzhyshkowska J, Utikal J, Goerdt S (2005) Interleukin-4 and dexamethasone counterregulate extracellular matrix remodelling and phagocytosis in type-2 macrophages. Scand J Immunol 61:10\u201317. https:\/\/doi.org\/10.1111\/j.0300-9475.2005.01524.x","journal-title":"Scandinavian Journal of Immunology"},{"issue":"3","key":"727_CR31","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/neuonc\/noq202","volume":"13","author":"D. A. Haas-Kogan","year":"2011","unstructured":"Haas-Kogan DA, Banerjee A, Poussaint TY, Kocak M, Prados MD, Geyer JR, Fouladi M, Broniscer A, Minturn JE, Pollack IF et al (2011) Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas. Neuro-Oncology 13:298\u2013306. https:\/\/doi.org\/10.1093\/neuonc\/noq202","journal-title":"Neuro-Oncology"},{"issue":"12","key":"727_CR32","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/nm.3716","volume":"20","author":"Rintaro Hashizume","year":"2014","unstructured":"Hashizume R, Andor N, Ihara Y, Lerner R, Gan H, Chen X, Fang D, Huang X, Tom MW, Ngo V et al (2014) Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma. Nat Med 20:1394\u20131396. https:\/\/doi.org\/10.1038\/nm.3716","journal-title":"Nature Medicine"},{"key":"727_CR33","doi-asserted-by":"publisher","unstructured":"Hashizume R, Zhang A, Mueller S, Prados MD, Lulla RR, Goldman S, Saratsis AM, Mazar AP, Stegh AH, Cheng SY et al (2016) Inhibition of DNA damage repair by the CDK4\/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth. Neuro-Oncology 18:1519\u20131528. https:\/\/doi.org\/10.1093\/neuonc\/now106","DOI":"10.1093\/neuonc\/now106"},{"key":"727_CR34","doi-asserted-by":"publisher","unstructured":"Hoeman CM, Cordero FJ, Hu G, Misuraca K, Romero MM, Cardona HJ, Nazarian J, Hashizume R, McLendon R, Yu P et al (2019) ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis. Nat Commun 10: 1023. https:\/\/doi.org\/10.1038\/s41467-019-08823-9","DOI":"10.1038\/s41467-019-08823-9"},{"key":"727_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40478-017-0436-6","volume":"5","author":"TY Huang","year":"2017","unstructured":"Huang TY, Piunti A, Lulla RR, Qi J, Horbinski CM, Tomita T, James CD, Shilatifard A, Saratsis AM (2017) Detection of histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma. Acta Neuropathol Commun 5:28. https:\/\/doi.org\/10.1186\/s40478-017-0436-6","journal-title":"Acta Neuropathol Commun"},{"key":"727_CR36","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1002\/jcp.22614","volume":"226","author":"T Ishigaki","year":"2011","unstructured":"Ishigaki T, Imanaka-Yoshida K, Shimojo N, Matsushima S, Taki W, Yoshida T (2011) Tenascin-C enhances crosstalk signaling of integrin alphavbeta3\/PDGFR-beta complex by SRC recruitment promoting PDGF-induced proliferation and migration in smooth muscle cells. J Cell Physiol 226:2617\u20132624. https:\/\/doi.org\/10.1002\/jcp.22614","journal-title":"J Cell Physiol"},{"key":"727_CR37","first-page":"489","volume":"25","author":"T Ishiwata","year":"2005","unstructured":"Ishiwata T, Takahashi K, Shimanuki Y, Ohashi R, Cui R, Takahashi F, Shimizu K, Miura K, Fukuchi Y (2005) Serum tenascin-C as a potential predictive marker of angiogenesis in non-small cell lung cancer. Anticancer Res 25:489\u2013495","journal-title":"Anticancer Res"},{"key":"727_CR38","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/bph.12452","volume":"171","author":"MS Islam","year":"2014","unstructured":"Islam MS, Kusakabe M, Horiguchi K, Iino S, Nakamura T, Iwanaga K, Hashimoto H, Matsumoto S, Murata T, Hori M et al (2014) PDGF and TGF-beta promote tenascin-C expression in subepithelial myofibroblasts and contribute to intestinal mucosal protection in mice. Br J Pharmacol 171:375\u2013388. https:\/\/doi.org\/10.1111\/bph.12452","journal-title":"Br J Pharmacol"},{"key":"727_CR39","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3171\/jns.1987.66.2.0227","volume":"66","author":"RD Jenkin","year":"1987","unstructured":"Jenkin RD, Boesel C, Ertel I, Evans A, Hittle R, Ortega J, Sposto R, Wara W, Wilson C, Anderson J et al (1987) Brain-stem tumors in childhood: a prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. A report of the Childrens Cancer Study Group. J Neurosurg 66:227\u2013233. https:\/\/doi.org\/10.3171\/jns.1987.66.2.0227","journal-title":"J Neurosurg"},{"key":"727_CR40","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/jcp.20527","volume":"206","author":"M Jinnin","year":"2006","unstructured":"Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K (2006) Platelet derived growth factor induced tenascin-C transcription is phosphoinositide 3-kinase\/Akt-dependent and mediated by Ets family transcription factors. J Cell Physiol 206:718\u2013727. https:\/\/doi.org\/10.1002\/jcp.20527","journal-title":"J Cell Physiol"},{"key":"727_CR41","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/sj.jid.5700090","volume":"126","author":"M Jinnin","year":"2006","unstructured":"Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K (2006) Upregulation of tenascin-C expression by IL-13 in human dermal fibroblasts via the phosphoinositide 3-kinase\/Akt and the protein kinase C signaling pathways. J Invest Dermatol 126:551\u2013560. https:\/\/doi.org\/10.1038\/sj.jid.5700090","journal-title":"J Invest Dermatol"},{"key":"727_CR42","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.theriogenology.2015.05.030","volume":"84","author":"L Jordaens","year":"2015","unstructured":"Jordaens L, Arias-Alvarez M, Pintelon I, Thys S, Valckx S, Dezhkam Y, Bols PE, Leroy JL (2015) Elevated non-esterified fatty acid concentrations hamper bovine oviductal epithelial cell physiology in three different in vitro culture systems. Theriogenology 84:899\u2013910. https:\/\/doi.org\/10.1016\/j.theriogenology.2015.05.030","journal-title":"Theriogenology"},{"key":"727_CR43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cyto.2013.02.007","volume":"62","author":"A Kasza","year":"2013","unstructured":"Kasza A (2013) IL-1 and EGF regulate expression of genes important in inflammation and cancer. Cytokine 62:22\u201333. https:\/\/doi.org\/10.1016\/j.cyto.2013.02.007","journal-title":"Cytokine"},{"key":"727_CR44","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","volume":"124","author":"DA Khuong-Quang","year":"2012","unstructured":"Khuong-Quang DA, Buczkowicz P, Rakopoulos P, Liu XY, Fontebasso AM, Bouffet E, Bartels U, Albrecht S, Schwartzentruber J, Letourneau L et al (2012) K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 124:439\u2013447. https:\/\/doi.org\/10.1007\/s00401-012-0998-0","journal-title":"Acta Neuropathol"},{"key":"727_CR45","doi-asserted-by":"publisher","first-page":"6942","DOI":"10.1158\/0008-5472.can-08-0347","volume":"68","author":"K Lange","year":"2008","unstructured":"Lange K, Kammerer M, Saupe F, Hegi ME, Grotegut S, Fluri E, Orend G (2008) Combined lysophosphatidic acid\/platelet-derived growth factor signaling triggers glioma cell migration in a tenascin-C microenvironment. Cancer Res 68:6942\u20136952. https:\/\/doi.org\/10.1158\/0008-5472.can-08-0347","journal-title":"Cancer Res"},{"key":"727_CR46","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fonc.2017.00057","volume":"7","author":"DH Lapin","year":"2017","unstructured":"Lapin DH, Tsoli M, Ziegler DS (2017) Genomic insights into diffuse intrinsic pontine glioma. Front Oncol 7:57. https:\/\/doi.org\/10.3389\/fonc.2017.00057","journal-title":"Front Oncol"},{"key":"727_CR47","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1093\/bioinformatics\/btt087","volume":"29","author":"N Leng","year":"2013","unstructured":"Leng N, Dawson JA, Thomson JA, Ruotti V, Rissman AI, Smits BM, Haag JD, Gould MN, Stewart RM, Kendziorski C (2013) EBSeq: an empirical Bayes hierarchical model for inference in RNA-seq experiments. Bioinformatics 29:1035\u20131043. https:\/\/doi.org\/10.1093\/bioinformatics\/btt087","journal-title":"Bioinformatics"},{"key":"727_CR48","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"key":"727_CR49","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1501354","volume":"2","author":"RR Lulla","year":"2016","unstructured":"Lulla RR, Saratsis AM, Hashizume R (2016) Mutations in chromatin machinery and pediatric high-grade glioma. Sci Adv 2:e1501354. https:\/\/doi.org\/10.1126\/sciadv.1501354","journal-title":"Sci Adv"},{"issue":"4","key":"727_CR50","doi-asserted-by":"publisher","first-page":"520-537.e5","DOI":"10.1016\/j.ccell.2017.08.017","volume":"32","author":"Alan Mackay","year":"2017","unstructured":"Mackay A, Burford A, Carvalho D, Izquierdo E, Fazal-Salom J, Taylor KR, Bjerke L, Clarke M, Vinci M, Nandhabalan M et al (2017) Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma. Cancer cell 32: 520-537.e525. https:\/\/doi.org\/10.1016\/j.ccell.2017.08.017","journal-title":"Cancer Cell"},{"issue":"5","key":"727_CR51","doi-asserted-by":"publisher","first-page":"829-842.e5","DOI":"10.1016\/j.ccell.2018.04.004","volume":"33","author":"Alan Mackay","year":"2018","unstructured":"Mackay A, Burford A, Molinari V, Jones DTW, Izquierdo E, Brouwer-Visser J, Giangaspero F, Haberler C, Pietsch T, Jacques TS et al (2018) Molecular, pathological, radiological, and immune profiling of non-brainstem pediatric high-grade glioma from the HERBY phase II randomized trial. Cancer cell 33: 829-842.e825. https:\/\/doi.org\/10.1016\/j.ccell.2018.04.004","journal-title":"Cancer Cell"},{"key":"727_CR52","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S0360-3016(98)00501-X","volume":"43","author":"LR Mandell","year":"1999","unstructured":"Mandell LR, Kadota R, Freeman C, Douglass EC, Fontanesi J, Cohen ME, Kovnar E, Burger P, Sanford RA, Kepner J et al (1999) There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys 43:959\u2013964","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"727_CR53","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1091\/mbc.e02-05-0292","volume":"13","author":"Kim S. Midwood","year":"2002","unstructured":"Midwood KS, Schwarzbauer JE (2002) Tenascin-C modulates matrix contraction via focal adhesion kinase\u2013 and rho-mediated signaling pathways. Mol Biol Cell 13:3601\u20133613. https:\/\/doi.org\/10.1091\/mbc.E02-05-0292","journal-title":"Molecular Biology of the Cell"},{"key":"727_CR54","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nm.4293","volume":"23","author":"F Mohammad","year":"2017","unstructured":"Mohammad F, Weissmann S, Leblanc B, Pandey DP, Hojfeldt JW, Comet I, Zheng C, Johansen JV, Rapin N, Porse BT et al (2017) EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas. Nat Med 23:483\u2013492. https:\/\/doi.org\/10.1038\/nm.4293","journal-title":"Nat Med"},{"key":"727_CR55","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ccell.2017.03.011","volume":"31","author":"S Nagaraja","year":"2017","unstructured":"Nagaraja S, Vitanza NA, Woo PJ, Taylor KR, Liu F, Zhang L, Li M, Meng W, Ponnuswami A, Sun W et al (2017) Transcriptional dependencies in diffuse intrinsic pontine glioma. Cancer Cell 31:635\u2013652 e636. https:\/\/doi.org\/10.1016\/j.ccell.2017.03.011","journal-title":"Cancer Cell"},{"key":"727_CR56","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1021\/pr5008653","volume":"14","author":"S Nie","year":"2015","unstructured":"Nie S, Gurrea M, Zhu J, Thakolwiboon S, Heth JA, Muraszko KM, Fan X, Lubman DM (2015) Tenascin-C: a novel candidate marker for cancer stem cells in glioblastoma identified by tissue microarrays. J Proteome Res 14:814\u2013822. https:\/\/doi.org\/10.1021\/pr5008653","journal-title":"J Proteome Res"},{"key":"727_CR57","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.canlet.2006.02.017","volume":"244","author":"G Orend","year":"2006","unstructured":"Orend G, Chiquet-Ehrismann R (2006) Tenascin-C induced signaling in cancer. Cancer Lett 244:143\u2013163","journal-title":"Cancer Lett"},{"key":"727_CR58","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/nm.2379","volume":"17","author":"T Oskarsson","year":"2011","unstructured":"Oskarsson T, Acharyya S, Zhang XH, Vanharanta S, Tavazoie SF, Morris PG, Downey RJ, Manova-Todorova K, Brogi E, Massague J (2011) Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med 17:867\u2013874. https:\/\/doi.org\/10.1038\/nm.2379","journal-title":"Nat Med"},{"key":"727_CR59","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1002\/1097-0142(19930815)72:4<1414::AID-CNCR2820720442>3.0.CO;2-C","volume":"72","author":"RJ Packer","year":"1993","unstructured":"Packer RJ, Boyett JM, Zimmerman RA, Rorke LB, Kaplan AM, Albright AL, Selch MT, Finlay JL, Hammond GD, Wara WM (1993) Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas. A Childrens Cancer Group Phase I\/II Trial. Cancer 72:1414\u20131421","journal-title":"Cancer"},{"key":"727_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021684","volume":"6","author":"I Paron","year":"2011","unstructured":"Paron I, Berchtold S, V\u00f6r\u00f6s J, Shamarla M, Erkan M, H\u00f6fler H, Esposito I (2011) Tenascin-C enhances pancreatic Cancer cell growth and motility and affects cell adhesion through activation of the integrin pathway. PLoS One 6:e21684. https:\/\/doi.org\/10.1371\/journal.pone.0021684","journal-title":"PLoS One"},{"key":"727_CR61","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nm.4296","volume":"23","author":"A Piunti","year":"2017","unstructured":"Piunti A, Hashizume R, Morgan MA, Bartom ET, Horbinski CM, Marshall SA, Rendleman EJ, Ma Q, Takahashi YH, Woodfin AR et al (2017) Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas. Nat Med 23:493\u2013500. https:\/\/doi.org\/10.1038\/nm.4296","journal-title":"Nat Med"},{"key":"727_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030313","volume":"7","author":"S Puget","year":"2012","unstructured":"Puget S, Philippe C, Bax DA, Job B, Varlet P, Junier MP, Andreiuolo F, Carvalho D, Reis R, Guerrini-Rousseau L et al (2012) Mesenchymal transition and PDGFRA amplification\/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas. PLoS One 7:e30313. https:\/\/doi.org\/10.1371\/journal.pone.0030313","journal-title":"PLoS One"},{"key":"727_CR63","doi-asserted-by":"publisher","first-page":"396","DOI":"10.4161\/cbt.9.5.10958","volume":"9","author":"K Rolle","year":"2010","unstructured":"Rolle K, Nowak S, Wyszko E, Nowak M, Zukiel R, Piestrzeniewicz R, Gawronska I, Barciszewska MZ, Barciszewski J (2010) Promising human brain tumors therapy with interference RNA intervention (iRNAi). Cancer Biol Ther 9:396\u2013406","journal-title":"Cancer Biol Ther"},{"key":"727_CR64","doi-asserted-by":"publisher","first-page":"7377","DOI":"10.1158\/0008-5472.can-04-1234","volume":"64","author":"C Ruiz","year":"2004","unstructured":"Ruiz C, Huang W, Hegi ME, Lange K, Hamou MF, Fluri E, Oakeley EJ, Chiquet-Ehrismann R, Orend G (2004) Growth promoting signaling by tenascin-C [corrected]. Cancer Res 64:7377\u20137385. https:\/\/doi.org\/10.1158\/0008-5472.can-04-1234","journal-title":"Cancer Res"},{"key":"727_CR65","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00401-013-1218-2","volume":"127","author":"AM Saratsis","year":"2014","unstructured":"Saratsis AM, Kambhampati M, Snyder K, Yadavilli S, Devaney JM, Harmon B, Hall J, Raabe EH, An P, Weingart M et al (2014) Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes. Acta Neuropathol 127:881\u2013895. https:\/\/doi.org\/10.1007\/s00401-013-1218-2","journal-title":"Acta Neuropathol"},{"key":"727_CR66","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/neuonc\/nos067","volume":"14","author":"AM Saratsis","year":"2012","unstructured":"Saratsis AM, Yadavilli S, Magge S, Rood BR, Perez J, Hill DA, Hwang E, Kilburn L, Packer RJ, Nazarian J (2012) Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid. Neuro-Oncology 14:547\u2013560. https:\/\/doi.org\/10.1093\/neuonc\/nos067","journal-title":"Neuro-Oncology"},{"key":"727_CR67","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1158\/0008-5472.can-16-2171","volume":"77","author":"S Sarkar","year":"2017","unstructured":"Sarkar S, Mirzaei R, Zemp FJ, Wei W, Senger DL, Robbins SM, Yong VW (2017) Activation of NOTCH signaling by tenascin-C promotes growth of human brain tumor-initiating cells. Cancer Res 77:3231\u20133243. https:\/\/doi.org\/10.1158\/0008-5472.can-16-2171","journal-title":"Cancer Res"},{"key":"727_CR68","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10833","volume":"482","author":"J Schwartzentruber","year":"2012","unstructured":"Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, Jacob K, Sturm D, Fontebasso AM, Quang DA, Tonjes M et al (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482:226\u2013231. https:\/\/doi.org\/10.1038\/nature10833","journal-title":"Nature"},{"key":"727_CR69","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1158\/0008-5472.can-08-2610","volume":"69","author":"B Sivasankaran","year":"2009","unstructured":"Sivasankaran B, Degen M, Ghaffari A, Hegi ME, Hamou M-F, Ionescu M-CS, Zweifel C, Tolnay M, Wasner M, Mergenthaler S et al (2009) Tenascin-C is a novel RBPJ\u03ba-induced target gene for Notch signaling in gliomas. Cancer Res 69:458\u2013465. https:\/\/doi.org\/10.1158\/0008-5472.can-08-2610","journal-title":"Cancer Res"},{"key":"727_CR70","doi-asserted-by":"publisher","first-page":"97304","DOI":"10.18632\/oncotarget.21937","volume":"8","author":"YC Song","year":"2017","unstructured":"Song YC, Lu GX, Zhang HW, Zhong XM, Cong XL, Xue SB, Kong R, Li D, Chang ZY, Wang XF et al (2017) Proteogenomic characterization and integrative analysis of glioblastoma multiforme. Oncotarget 8:97304\u201397312. https:\/\/doi.org\/10.18632\/oncotarget.21937","journal-title":"Oncotarget"},{"key":"727_CR71","doi-asserted-by":"publisher","first-page":"111190","DOI":"10.18632\/oncotarget.22704","volume":"8","author":"ST Sredni","year":"2017","unstructured":"Sredni ST, Bailey AW, Suri A, Hashizume R, He X, Louis N, Gokirmak T, Piper DR, Watterson DM, Tomita T (2017) Inhibition of polo-like kinase 4 (PLK4): a new therapeutic option for rhabdoid tumors and pediatric medulloblastoma. Oncotarget 8:111190\u2013111212. https:\/\/doi.org\/10.18632\/oncotarget.22704","journal-title":"Oncotarget"},{"issue":"25","key":"727_CR72","doi-asserted-by":"publisher","first-page":"17699","DOI":"10.1074\/jbc.M113.546622","volume":"289","author":"Rika Tanaka","year":"2014","unstructured":"Tanaka R, Seki Y, Saito Y, Kamiya S, Fujita M, Okutsu H, Iyoda T, Takai T, Owaki T, Yajima H et al (2014) Tenascin-C-derived peptide TNIIIA2 highly enhances cell survival and platelet-derived growth factor (PDGF)-dependent cell proliferation through potentiated and sustained activation of integrin \u03b15\u03b21. J Biol Chem 289:17699\u201317708. https:\/\/doi.org\/10.1074\/jbc.M113.546622","journal-title":"Journal of Biological Chemistry"},{"key":"727_CR73","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/ng.2925","volume":"46","author":"KR Taylor","year":"2014","unstructured":"Taylor KR, Mackay A, Truffaux N, Butterfield Y, Morozova O, Philippe C, Castel D, Grasso CS, Vinci M, Carvalho D et al (2014) Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma. Nat Genet 46:457\u2013461. https:\/\/doi.org\/10.1038\/ng.2925","journal-title":"Nat Genet"},{"issue":"9","key":"727_CR74","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/bioinformatics\/btp120","volume":"25","author":"Cole Trapnell","year":"2009","unstructured":"Trapnell C, Pachter L, Salzberg SL (2009) TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25. https:\/\/doi.org\/10.1093\/bioinformatics\/btp120","journal-title":"Bioinformatics"},{"key":"727_CR75","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/bpa.12042","volume":"23","author":"S Venneti","year":"2013","unstructured":"Venneti S, Garimella MT, Sullivan LM, Martinez D, Huse JT, Heguy A, Santi M, Thompson CB, Judkins AR (2013) Evaluation of histone 3 lysine 27 trimethylation (H3K27me3) and enhancer of zest 2 (EZH2) in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant glioblastomas. Brain Pathol 23:558\u2013564. https:\/\/doi.org\/10.1111\/bpa.12042","journal-title":"Brain Pathol"},{"key":"727_CR76","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fonc.2012.00205","volume":"2","author":"KE Warren","year":"2012","unstructured":"Warren KE (2012) Diffuse intrinsic pontine glioma: poised for progress. Front Oncol 2:205. https:\/\/doi.org\/10.3389\/fonc.2012.00205","journal-title":"Front Oncol"},{"key":"727_CR77","doi-asserted-by":"publisher","first-page":"561459","DOI":"10.1155\/2014\/561459","volume":"2014","author":"P Wojdasiewicz","year":"2014","unstructured":"Wojdasiewicz P, Poniatowski LA, Szukiewicz D (2014) The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediat Inflamm 2014:561459. https:\/\/doi.org\/10.1155\/2014\/561459","journal-title":"Mediat Inflamm"},{"key":"727_CR78","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ng.1102","volume":"44","author":"G Wu","year":"2012","unstructured":"Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J, Qu C, Ding L, Huether R, Parker M et al (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44:251\u2013253. https:\/\/doi.org\/10.1038\/ng.1102","journal-title":"Nat Genet"},{"key":"727_CR79","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/19336918.2015.1008332","volume":"9","author":"T Yoshida","year":"2015","unstructured":"Yoshida T, Akatsuka T, Imanaka-Yoshida K (2015) Tenascin-C and integrins in cancer. Cell Adhes Migr 9:96\u2013104. https:\/\/doi.org\/10.1080\/19336918.2015.1008332","journal-title":"Cell Adhes Migr"},{"key":"727_CR80","doi-asserted-by":"publisher","first-page":"R14","DOI":"10.1186\/gb-2010-11-2-r14","volume":"11","author":"MD Young","year":"2010","unstructured":"Young MD, Wakefield MJ, Smyth GK, Oshlack A (2010) Gene ontology analysis for RNA-seq: accounting for selection bias. Genome Biol 11:R14. https:\/\/doi.org\/10.1186\/gb-2010-11-2-r14","journal-title":"Genome Biol"},{"key":"727_CR81","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1128\/JVI.72.12.9873-9880.1998","volume":"72","author":"R Zufferey","year":"1998","unstructured":"Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, Trono D (1998) Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72:9873\u20139880","journal-title":"J Virol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0727-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-019-0727-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0727-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T01:51:04Z","timestamp":1663465864000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-019-0727-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,15]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["727"],"URL":"https:\/\/doi.org\/10.1186\/s40478-019-0727-1","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,15]]},"assertion":[{"value":"19 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent for specimen collection and analysis was obtained under protocols approved by Ann & Robert H. Lurie Children\u2019s Hospital of Chicago (IRB #2012\u201314877), Northwestern University (STU00200351, STU00202063) and Children\u2019s National Medical Center (IRB 1339, Study Pro00001339) Institutional Review Boards. This study was performed in accordance with the ethical standards of the Ann & Robert H. Lurie Children\u2019s Hospital of Chicago, Northwestern University and Children\u2019s National Medical Center their respective Research Committees and Institutional Review Boards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This manuscript does not contain personal data in any form. All patient identifiers were removed prior to biological specimen analysis, and only deidentified results are presented.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"75"}}